Human tumours which grow and metastasize in immunodeficient animals are amenable to controlled investigation of human tumour metastasis in the presence of the original tumour inoculum. In previous reports (Ware et al., 1982 (Ware et al., , 1984 , we described a unique human prostate carcinoma subline, l-LN-PC-3-lA, which consistently metastasizes from a subcutaneous (s.c.) site to both regional and distant lymph nodes in tumour-excised adult athymic nude mice. These tumour cells also form multiple lung micrometastases in 30-50% of tumour-excised mice (Ware et al., 1984) .
We have used this model system to address two basic questions concerning spontaneous metastasis of the human prostate carcinoma subline 1-LN-PC-3-lA growing subcutaneously in adult nude mice: (i) What are the characteristics of metastasis by these cells in the presence of the original s.c. tumour, and (ii) Is the size of the s.c. tumour a significant determinant of lymphatic metastasis in this experimental system? Male athymic nude mice (nu/nu) (BALB/ cAnBOM), 6-8 weeks old, were used in all experiments. Specific pathogen-free mice were obtained from two sources. Groups 1 and 2 were purchased from Harlan-Sprague Dawley (Indianapolis, Indiana). These mice were received from the supplier at the age of 4-5 weeks and allowed to acclimatize for 2 more weeks in a barrier facility prior to any experimentation. Groups 3 and 4 were obtained from the breeding colony of athymic nude mice maintained by the Urology Research Laboratories, Duke University Medical Center. All of these mice (groups 1, 2, 3 and 4) were provided with sterile food, water, bedding and cages, and maintained in an isolated barrier facility with strict access limitations. Heterozygous (nu/+) mice were maintained under the same conditions as the experimental animals to act as additional monitors for microbial contamination. No evidence of nonspecific bacterial contamination or parasitic infection was found for mice involved in these experiments. Furthermore, sera from the heterozygous sentinal mice were screened by the Veterinary Diagnostic Laboratory, University of Missouri School of Veterinary Medicine (Columbus, Missouri) and found to be free of significant titres of antibody to any of the 11 most common murine viruses, including murine hepatitis virus.
The utilization of mice from 2 different suppliers served two functions. It allowed inclusion of sufficient numbers of nude mice in each group to permit meaningful statistical analysis and it also ensured that the results obtained would not be unique to mice from a single source. The mice were divided into 4 chronologically spaced groups, 2 from each supplier, in an effort to eliminate time and batch biases and thus to allow identification of effects which would be general across time.
Human prostate carcinoma cells designated 1-LN-PC-3-IA were derived from a spontaneous lymph node metastasis originating in a nude mouse bearing a PC-3-IA tumor as described previously (Ware et al., 1982) . PC 3-lA (Ware et al., 1982) was obtained from the established human prostate carcinoma cell line PC-3 (Kaighn et al., 1979) . Cells used in these experiments were recovered from frozen stocks stored in liquid nitrogen and maintained in vitro no more than 3 weeks prior to injection. These cells were grown in RPMI 1640 supplemented with 10% heat-inactivated calf serum (HYCLONE Laboratories, Logan, Utah) and gentimicin (50mg 1-1 (Steele, 1977; Norton & Simon, 1979) . The tumours described in this study appeared to grow as prolate spheroids during the exponential phase of growth and the tumour volumes used in this analysis were measured during that phase.
The average s.c. tumour volume doubling time was 3.5 days. On the day of sacrifice, the s.c. tumour was removed and weighed. The site of the original tumour inoculum, designated "primary", was examined for gross evidence of invasion of muscle or the peritoneal membrane. At autopsy the left and right inguinal lymph nodes, the axillary lymph nodes, and the brachial lymph nodes were removed and preserved in 10% buffered formalin. Any grossly enlarged internal lymph nodes, as well as the lungs, were also removed and preserved for histological examination.
Lymph nodes were embedded in paraffin and semi-serially sectioned (5 ym thickness) at 80 ,m intervals. Lungs were subjected to routine sectioning procedures which had previously disclosed multiple lung micrometastases in tumourexcised mice (Ware et al., 1984) . All tissues were stained with hematoxylin and eosin. Micrometastases were defined as a focus of 20 or more tumour cells detected in a 5 ym section. Lymph nodes removed from mice later than 21 days after injection often contained hundreds of tumour cells which displaced half of the normal lymphoid architecture.
In order to determine which variables significantly influenced development of micrometastases, logistic regression analyses were performed. This type of analysis models the probability of response (in this case, development of histologically detectable metastases) as a logistic function of the variables considered. This approach is commonly used in bioassay experiments (Finney, 1978) . To evaluate whether other effects were being confounded by sacrifice time, we performed all analyses with and without controlling for time of sacrifice. Linear contrasts were used to detect effects due to different sacrifice times (Steel & Torrie, 1980) . The 1-LN-PC-3-lA cells consistently metastasized to the superficial lymph nodes of adult athymic nude mice in the presence of the original s.c. tumour. Both regional and distant lymphatic metastases were observed among these mice. Internal lymph node metastases were also found in mice sacrificed at 31 or 36 days. Furthermore, internal lymphatic metastases were present in some mice which were free of superficial lymphatic metastases. Three mice sacrificed at day 31 and two mice sacrificed at 36 days had enlarged renal and/or paraaortic lymph nodes with histologically confirmed metastases. However, all superficial lymph nodes, including the ipsilateral inguinal lymph node, were free of micrometastases. Lung micrometastases were rarely found during routine sectioning (1/8 mice sacrificed 36 days after s.c. injection). Only 4/58 mice examined had s.c. tumours which were macroscopically invasive at autopsy.
As indicated in Table I , for the combined data from groups 1, 2, 3 and 4, 11/15 (73%) mice sacrificed 21 days after injection had 1 or more lymphatic metastases, while 9/18 (50%) mice had micrometastases at day 26. Among mice sacrificed 31 and 36 days after injection, metastases were detected in 12/17 (71%) and 7/8 (88%) respectively. The logistic regression analysis indicated no significant difference in probability of metastases due to time of sacrifice (P=0.27). However, in a preliminary analysis of groups 1, 2 and 3, a pronounced reduction in incidence of metastases was noted at day 26. Linear contrasts on this effe-t pinpointed a barely significant (P=0.05) decrease in percentage of mice with metastases between days 21 (75%) and 26 (36%), followed by an increase (P=0.06) from day 26 to day 31 (71%). The mean number of lymph node metastases per mouse was (Figure 1 Table I ).
In general, the size of s.c. tumour correlated positively with the probability of lymphatic metastasis, i.e., the. larger the tumour, the greater the likelihood of lymphatic metastasis. The most influential variable in our analyses was tumour volume 20 days after s.c. injection (VOL20). Regardless of which combinations of variables were modeled, VOL20 consistently emerged as a statistically significant predictor of tumour metastases, with higher volume yielding higher probabilities of metastases (Table II) . Tested alone in the model using the combined data from groups 1, 2, 3, and 4, VOL20 had a P-value of 0.004; after controlling for day of sacrifice, the P-value remained at 0.006. Furthermore, the effect was consistent over the four sacrifice dates (i.e., there was not a statistically significant, nor visually evident, interaction effect between this variable and day of sacrifice). Volume measured on Day 9 also correlated positively with the probability of metastasis, but was less significant statistically (P=0.07). The greater significance of s.c. volume calculated at Day 20 may have reflected greater accuracy in caliper measurements. Nine days postinjection was the earliest date at which the s.c. tumours were measurable, and accurate length and width measurements were more difficult to obtain at Day 9, thus contributing to greater potential error in volume calculations.
The weight of the s.c. tumour at the time of sacrifice also had a positive influence on development of metastases (P = 0.03 alone and P=0.02 after controlling for sacrifice time) (Table  III) . This result is consistent with the finding for volume at day 20, since tumour weight and volume are highly correlated. In fact, among those mice sacrificed at Day 21, the correlation between volume at Day 20 and sacrifice weight was 0.85 (P=0.0001).
The relation between specific growth parameters of a primary tumour and its metastases may be positive, negative, or nonexistent, depending upon the host/tumour system examined. The metastatic behaviour of several animal tumours has been shown to be influenced by the presence or absence (Gorelik, 1983) , size (Anderson et al., 1974) , and/or growth rate (Dewys, 1972) of the primary tumour. Incidence of metastases (from Table I In other cases, no correlation between growth rate (Hager et al., 1978) or primary tumour size (Price et al., 1982) and metastatic incidence has been observed. Using logistic regression analyses, we demonstrated that the size of the s.c. tumour correlated positively with the probability of lymphatic metastasis among these 58 nude mice. The most influential variable was the calculated s.c. tumour volume 20 days after inoculation. After controlling for time (day of sacrifice), VOL20 was still a significant factor. Thus s.c. tumour size, rather than duration of growth, appeared to be the important parameter. Furthermore, the weight of the s.c. tumour at the day of sacrifice also had a positive influence on development of metastases. Thus the findings for two different expressions of tumour size were consistent with each other.
We believe that our randomized design enhances the significance of these results. Immediately after tumour inoculation, each mouse received a randomly generated sacrifice time (21, 26, 31, or 36 days) . Thus no subconscious bias could have led us to consistently sacrifice mice with certain attributes, e.g., large tumours, either early or late in the schedule.
We also believe that our statistical analysis is the appropriate one for this study design. Rather than comparing results obtained at individual sacrifice days separately, we have incorporated data for all sacrifice days into a unified analysis. We have thus enhanced the power of analysis while decreasing the number of statistical tests performed.
The mean number of metastases per mouse was relatively constant, 1-2 per mouse. This contrasts with previous investigations of the l-LN-PC-3-lA line in tumour-excised nude mice. Among mice sacrificed 4 weeks after tumour excision (8 weeks post-injection), multiple lymph node metastases were often found per mouse and lung micrometastases were demonstrable in half the mice in routine lung sections (Ware et al., 1984; Ware, unpublished observations) . These experiments are not strictly comparable to the ones described in this report due to temporal differences. Nonetheless, the rarity of pulmonary micrometastases and the restriction of the number of lymphatic metastases per mouse among tumour-bearing mice were striking. This apparent difference in metastatic dissemination between tumor-excised and tumourbearing mice has been observed by other investigators working with human tumours grown in nude mice. The excision of several human melanomas (Wilson et al., 1980) , human breast carcinomas (Ozzello & Sordat, 1980) , and human colon carcinoma cells (Sordat et al., 1982) growing s.c. is reported to promote or permit greater dissemination of these tumours in adult nude mice.
As a variation on approaches taken by other investigators, we chose to begin analyzing the relation between the size of a human tumour and its metastases in nude mice without disturbing (i.e., excising) the s.c. tumour. Application of statistical methodology in both experimental design and interpretation of the data permitted identification of a positive correlation between s.c. tumour size and the probability of lymphatic metastasis by the human prostate carcinoma cells, 1-LN-PC-3-lA. This finding provides a foundation for future experimental analysis of the mechanisms underlying this size-metastasis relation for a human tumour growing in a nude mouse.
